about ethacridine compatibility trimester pregnancy termination of the clinical observation of mifepristone（关于ethacridine兼容性终止怀孕三个月的临床观察米非司酮）.docVIP

About ethacridine compatibility trimester pregnancy termination of the clinical observation of mifepristone [Abstract] Objective To observe the intra-amniotic injection ethacridine trimester pregnancy termination of the clinical effects of mifepristone compatibility and safety of methods of the future site for intrauterine pregnancy 14-26W voluntary termination of pregnancy in healthy women required 300 patients randomly divided into two groups and the control group, two groups were characterized by abdominal intra-amniotic injection ethacridine 100mg, while the observation group fasting oral mifepristone tablets 75mg, 12h a total of 150mg, the control group while fasting oral vitamin B6 tablets 20mg, 12h time, the total amount of 40mg, effects were observed induction of labor and safety, the success rate of induction of labor results of two groups no significant difference (Pgt; 0.05) the observation group: uterine contractions until the baby is delivered a short time, 2h post-partum bleeding, abdominal pain, light, low incidence of cervical laceration, significantly lower than the control group (p lt;0.05) observed group only mild nausea, vomiting and dizziness response, the control group, no significant discomfort. Conclusion ethacridine compatibility meters trimester pregnancy termination non-Division ketone, induction time is short, less postpartum bleeding, pain, low incidence of cervical laceration, is safe and effective method for induction. [Keywords] ethacridine trimester mifepristone Ethacridine intra-amniotic injection for clinical application in mid-pregnancy abortion 40 years ago, one of the most commonly used method, but there is a long time, too strong contractions, uncoordinated contractions, cervical laceration, pain re- such as lack of subsequent pregnancy after cesarean section in particular, induction of labor, the more likely to idle state, this paper ethacridine compatibility of mifepristone to terminate second trimester pregnancy